[Translation] A randomized, double-blind, parallel-controlled, multicenter phase Ⅱa clinical trial on the efficacy and safety of Renshu Changle Granules in the treatment of diarrhea-predominant irritable bowel syndrome (liver depression and spleen deficiency syndrome)
对仁术肠乐颗粒治疗腹泻型肠易激综合征(肝郁脾虚证)进行剂量探索,同时初步评价其有效性和安全性,为后续临床试验提供数据支持。
[Translation] A dose exploration was conducted on Renshu Changle Granules in the treatment of diarrhea-predominant irritable bowel syndrome (liver depression and spleen deficiency syndrome), and its effectiveness and safety were preliminarily evaluated to provide data support for subsequent clinical trials.